Buscar resultados de ensayos clínicos

Patrocinado por

Acute Leukemia of Ambiguous Lineage - 21 Studies Found

Estado Estudiar
Completed Nombre del estudio: A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL)
Condición: Leukemia
Fecha: 2014-05-08
Intervenciones:
  • Drug: Clofarabine

Terminated Nombre del estudio: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Condición:
  • Mixed Lineage Acute Leukemia
  • Acute Myeloid Leukemia
  • Fecha: 2015-04-14
    Intervenciones:
    • Drug: Bortezomib Bortezomib wi
Completed Nombre del estudio: Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia
Condición:
  • Acute Leukemias of Ambiguous Lineage
  • Philadelphia Chromosome Ne
    Fecha: 2010-05-26
    Intervenciones:
    • Drug: entinostat Given PO
Recruiting Nombre del estudio: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Condición:
  • Acute Biphenotypic Leukemia
  • Acute Myeloid Leukemia
  • Fecha: 2016-03-14
    Intervenciones:
    • Drug: Cladribine Given IV
Active, not recruiting Nombre del estudio: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
Condición:
  • Acute Biphenotypic Leukemia
  • Acute Myeloid Leukemia
  • Fecha: 2013-03-01
    Intervenciones:
    • Other: Laboratory Biomarker Analysis

Completed Nombre del estudio: Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
Condición:
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Drug: Selinexor Given orally o
Recruiting Nombre del estudio: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Condición:
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acut
    Fecha: 2014-08-18
    Intervenciones:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruiting Nombre del estudio: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
Condición:
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acut
    Fecha: 2013-05-15
    Intervenciones:
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting Nombre del estudio: Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Condición:
  • de Novo Myelodysplastic Syndrome
  • Mixed Phenotype Acute Leukemia
    Fecha: 2016-09-29
    Intervenciones:
    • Drug: Cladribine Given IV
Terminated Nombre del estudio: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
Condición:
  • Acute Leukemias of Ambiguous Lineage
  • Acute Undifferentiated Leu
    Fecha: 2009-07-07
    Intervenciones:
    • Drug: dexrazoxane hydrochloride

Next >>>